Biogen Pharmachem Industries L
- Jurisdiction
India - ISIN
INE703D01023 (BIOGEN.BO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
2
/ 9
Profile
Biogen Pharmachem Industries Ltd. engages in the business of trading in shares and securities. Read full profile
Stock price
Fundamentals
- Net revenue
€164.45K - Gross margin
73.2% - EBIT
€97.34K - EBIT margin
59.2% - Net income
€97.34K - Net margin
59.2%
Statement period: - (published )
Dividends
No dividend payouts